CPT code 33362 represents transcatheter aortic valve implantation (TAVI/TAVR) in which an aortic valve prosthesis is inserted through the lumen of a catheter using an open femoral artery approach. This procedural code captures catheter-based aortic valve replacement when direct femoral arterial exposure is used, an important distinction for coding, billing, and clinical documentation across hospitals and cardiac centers. Nationally, TAVR procedures are a major component of structural heart interventions and carry implications for payment, resource allocation, and perioperative care pathways.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical service represented by the code, typical site-of-service considerations, and the payer landscape relevant to this procedure. The publication outlines benchmarks, common billing modifiers (where data is available), and contextual clinical notes that clarify when this code applies versus other transcatheter aortic valve codes. It also highlights policy and billing considerations that affect reimbursement and documentation requirements for hospitals and cardiac service lines.

The report is designed for coding professionals, hospital revenue leaders, and clinicians involved in structural heart programs who need a clear reference for CPT code 33362, its clinical context, and how it aligns with national payer coverage patterns and administrative practices.